Delivery Order SPE2DB25D7056-SPE2DB25FTNFA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Doxycycline 50 mg tablets (60-count) with a ceiling value of $7,399.24 under a firm fixed-price contract type. The award was issued on August 5, 2025, with an ultimate completion date of August 6, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, is the location of performance for this pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $10,374.00 to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets (300 count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded contract utilizes firm fixed pricing with no set-aside designation. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office. This...
- The Defense Logistics Agency awarded a $20,468.22 delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Doxycycline 50 mg on July 29, 2025, with an ultimate completion date of July 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 500 units, with a contract ceiling value of $2,077.68. This is a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units at a firm fixed price ceiling value of $2,952.00. This contract, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,232.51 for Doxycycline 50 mg tablets (60-count units) on August 21, 2025, with completion scheduled for August 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction within AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, with a ceiling value of $3,597.84. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Doxycycline Hyclate with a ceiling value of $3,511.51. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for ultimate completion on August 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Doxycycline Hyclate with a ceiling value of $5,456.11. This firm fixed-price delivery order, which is not set-aside and competitively awarded, is scheduled for completion by September 30, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement...
- This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,568,173,863 units of doxycycline monohydrate 100 mg capsules. The $4,487.10 firm fixed-price delivery order has a performance period through May 8, 2025 and is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of...
- SPE2DB25D7056Indefinite Delivery Contract
- SPE2DB25D7056-SPE2DB25FTNFADelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $1,994.11 for the supply of Doxycycline 25 mg/5 ml suspension in 60 ml quantities. This award was issued on September 12, 2025, with an ultimate completion date of September 15, 2025, under a firm fixed price delivery order with no set-aside designation. The contract represents a competitive award within the pharmaceutical procurement landscape supporting federal medical supply needs. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The doxycycline procurement supports critical antibiotic needs for defense and military medical operations, positioning this small-value delivery order within AmerisourceBergen's extensive portfolio of federal pharmaceutical supply contracts serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/12/25 |